Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HuaAn Fund Management Co., Ltd. ("HuaAn Funds") is one of the first five domestic fund management companies approved by the China Securities Regulatory Commission. Founded in 1998 and headquartered in Shanghai, it manages a broad range of mutual funds and asset management products. As of late 2024, it manages 275 mutual funds with total assets under management (AUM) of CNY 410 billion (excluding money market funds), serving over 1.3 billion individual clients[2][3]. The company has a wholly owned overseas subsidiary in Hong Kong—HuaAn Asset Management (Hong Kong)—licensed for securities dealing and asset management activities[3][7]. There are no indications that this company operates in life sciences, biotech, pharma, or healthcare sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HuaAn Fund Management.